
Corix Bioscience Inc. Stock Analysis CXBS
Corix Bioscience, Inc. is an emerging growth company, which engages in the provision, extraction, and cultivation of cannabidiol. The company is headquartered in Tully, New York. The company went IPO on 2009-04-08. The firm is engaged in providing cannabidiol (CBD) oil, which is used for a wide variety of medicinal purposes. The company is also engaged in cultivating and extracting tetrahydrocannabivarin (THCV) oil. The company clones all of its plants based off of three original types: Otto, Cherry Wine and Georges Pet. The company operates in Oregon, California and Nevada, United States.
Read More Corix Bioscience Inc (CXBS) Chart
Key Statistics of Corix Bioscience Inc (CXBS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
-P/E Ratio (TTM)
-52 Week Range
Market Cap
4004.50Avg. Volume
-Dividend Yield
-Financial Metrics & Statements of Corix Bioscience Inc (CXBS)
FAQ's for Corix Bioscience Inc (CXBS)
- According to Musaffa’s Shariah screening methodology, Corix Bioscience Inc (CXBS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.